VNDA · Forms 3, 4, 5

Insider trades at Vanda Pharmaceuticals Inc.

No open-market insider buys or sells at Vanda Pharmaceuticals Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for Vanda Pharmaceuticals Inc. (VNDA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Most recent insider filings

No Form 3, 4 or 5 filings for Vanda Pharmaceuticals Inc. in the last 90 days. The latest ones on EDGAR:

DateInsiderRoleTransactionSharesPriceValueFiling
Daniel Patrick McGuireSVP, GC and SecretaryBecame an insider (Form 3)Form 3
Daniel Patrick McGuireSVP, GC and SecretaryAward80,000Form 4
Phaedra ChrousosDirectorAward41,600Form 4
Charles Cliff DuncanDirectorAward41,600Form 4
Richard W DuganDirectorAward41,600Form 4
Anne Sempowski WardDirectorAward41,600Form 4
Tage HonoreDirectorAward41,600Form 4
Stephen Ray MitchellDirectorAward41,600Form 4
Stephen Ray MitchellDirectorGift25,836Form 4
Charles Cliff DuncanDirectorAward57,101Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.